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Abstract
OBJECTIVE—The objective of the study was to investigate the association between maternal 
self-reported infections, fever, and smoking in the prenatal period and the subsequent risk for 
congenital cerebral palsy (CP).
STUDY DESIGN—We included the 81,066 mothers of singletons born between 1996 and 2003 
who participated in the Danish National Birth Cohort. Children were followed up through 
December 2008. Information on maternal infections, fever, smoking, and other demographic and 
lifestyle factors during pregnancy were reported by mothers in computer-assisted telephone 
interviews in early and midgestation. We identified 139 CP cases including 121 cases of spastic 
CP (sCP) as confirmed by the Danish National Cerebral Palsy Register. Cox proportional hazards 
regression models were used to estimate adjusted hazard ratios (aHRs) and 95% confidence 
intervals (CIs).
RESULTS—Self-reported vaginal infections were associated with an increased risk of CP and 
sCP (aHR, 1.52; 95% CI, 1.04–2.24; and aHR, 1.73; 95% CI, 1.16–2.60, respectively) and 
particularly untreated vaginal infections were associated with an increased risk of sCP (aHR, 1.95; 
95% CI, 1.16–3.26). Fever was associated with the risk of CP (aHR, 1.53; 95% CI, 1.06–2.21). 
Smoking 10 or more cigarettes per day during pregnancy was also associated with sCP (aHR, 
1.80; 95% CI, 1.10–2.94). There was a modest excess in risk for children exposed to both heavy 
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smoking and vaginal infections. No other self-reported infections were significantly associated 
with CP.
CONCLUSION—Self-reported vaginal infections, fever, and smoking 10 or more cigarettes per 
day during pregnancy were associated with a higher risk of overall CP and/or sCP.
Keywords
congenital cerebral palsy; maternal infections; pregnancy; smoking
Congenital cerebral palsy (CP) constitutes a group of permanent disorders of movement and 
posture causing activity limitation attributed to non-progressive disturbances that occurred 
in the developing fetal or infant brain.1 CP is the most common physical developmental 
disability in childhood with a birth prevalence of 2 per 1000 live births in Denmark.2,3 The 
incidence of CP increases with lower gestational age, up to 100 cases per 1000 births in 
extreme preterm cases (<28 weeks).4,5 Improvements in perinatal care and neonatal survival 
in recent decades have increased the survival of children born preterm and therefore the 
number of CP cases.4,6
Maternal fever7,8 and maternal infections9–11 have been associated with an increased risk of 
CP, irrespective of gestational age. Infections of the vagina or urinary tract during pregnancy 
have been of special interest because of their proximity to the fetus, but most studies have 
not clearly separated these infections. Self-reported data from questionnaires administered 
during pregnancy provide separation of each type of infection and more importantly include 
infections that did not receive medical attention. The proposed mechanism of action for 
maternal infections increasing risk of CP is by triggering a fetal inflammatory response, 
which results in fetal brain damage, particularly if added to fetal hypoxia.12
Smoking 10 or more cigarettes during pregnancy has also been associated with CP.13 The 
possible mechanism of action of this association is by the creation of a pathological hypoxic 
environment for the fetus.13 Moreover, smoking has also been associated with vaginal 
infections.14 We therefore hypothesize that exposure both maternal infection and maternal 
smoking may result in excess risk of CP in comparison with either exposure alone.
Maternal age,15–17 smoking during pregnancy,14,18 alcohol consumption,14,19 
socioeconomic status,20–22 household size during pregnancy,14,22 season of pregnancy 
start,23,24 and calendar year of birth2,25 may confound the association between infection and 
CP. These factors have been shown to be associated with an increased risk of CP as well as 
being associated with increased risk of infections.
This study explores the association between CP and self-reported maternal infections during 
pregnancy, using the Danish National Birth Cohort and the Danish National Cerebral Palsy 
Registry. We analyzed all infections combined and separately as well as fever (a marker of 
infection). We specifically focused on the association between CP and self-reported vaginal 
infections, urinary tract infections, or smoking, adjusting for available confounders. Because 
there might be specific etiological links between infection and spastic CP (sCP),26 we 
analyzed this group separately.
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Materials and Methods
The Danish National Birth Cohort is a nationwide population-based cohort of pregnancies 
and their offspring designed to provide questionnaires for collecting self-reported data for 
epidemiological studies of short-term and long-term consequences of intrauterine exposures. 
Details on the Danish National Birth Cohort study design and recruitment procedures have 
been published elsewhere, 27 and the translated questionnaires are available (www.dnbc.dk).
We included women in our study only if they participated in both of the 2 interviews during 
pregnancy (n = 83,935). We additionally excluded 2447 non-singleton children, 261 
children who died, and 118 children who emigrated prior to their first birthday, and 43 
children who were not in the Danish Medical Birth Registry. Of the 261 children who died, 
186 died neonatally (within the first 30 days after delivery). This study was approved by the 
Danish Data Protection Agency. The study was also approved and by the Research Ethic 
Committee and University of California, Los Angeles, Institutional Review Boards.
Danish National Birth Cohort participants were identified as having validated CP if they 
were alive after the first year of life and included in the Danish Cerebral Palsy Registry. 
Validation of CP cases and inclusion in the register has been previously described.28 Time 
of CP onset for the analysis was defined as age 1 year or first recorded date of diagnosis in 
the Danish Cerebral Palsy Registry. If a child’s date of diagnosis was prior to the age of 1 
year (n = 76), the child’s date of diagnosis was recentered to the date of child’s first birthday 
(date of birth plus 365 days) and coded as a CP child if included in the CP registry. All 
children were followed up from 1 year of age until a reported diagnosis of CP in the Danish 
Cerebral Palsy Registry, death, or Dec. 31, 2008, whichever occurred first.
Information on urinary tract infections (cystitis, pyelonephritis), vaginal infections, diarrhea, 
cough, genital herpes, venereal warts, herpes labialis, fever, and smoking was collected from 
participants as part of the Danish National Birth Cohort interviews.
Because the etiology of CP is largely unknown, confounding adjustment is based on 
availability of data and previous findings. Information on maternal age at birth and calendar 
year of birth was obtained from the Danish Medical Birth Registry, whereas information on 
other confounders (smoking during pregnancy, alcohol consumption, socioeconomic status, 
household size during pregnancy) was available from interviews.
Coding of social status was based on highest self-reported education and job titles between 
both parents at the time of recruitment. Parents who had a completed education 4 years 
beyond secondary school education or were in management were classified as high social 
status. Parents with middle-range training and skilled workers were classified as middle 
social status, and unskilled workers and unemployed were classified as low social status. If 
unemployed more than 12 months, parents were categorized in the lowest category, if 
unemployed less than 12 months, parents’ completed education and or training were used to 
determine status.
Women were classified into alcohol consumption categories based on the maximum 
consumption at any point in time during their pregnancy, as described in either of the 2 
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interviews. Binge drinking was having at least 1 episode of intake of 5 drinks or more in 1 
night during pregnancy. In addition to potential confounders, we collected information 
concerning gestational age (in weeks) at birth, and Apgar score at 5 minutes from the Danish 
Medical Birth Registry.
Characteristics of maternal cohort across maternal infection and smoking groups were 
summarized as proportions and analyzed using χ2 tests. For each infectious exposure group, 
we modeled the risk of CP and the risk of sCP. Hazard ratios and 95% confidence intervals 
(CIs) were estimated by Cox proportional hazard regression models with person-years as the 
time-to-event variable using robust sandwich covariance estimates to take into account 
interdependency among women who had more than 1 child during the cohort recruitment 
time and therefore participated more than once in the cohort (4997 women participated in 
the cohort twice and 56 women participated 3 times). Adjusted hazard ratios included all 
potential confounders listed above. Confounders were selected for adjustment in CP and sCP 
models a priori based on literature review.
Multiple imputation methods were used to replace missing covariate data. The procedure 
generated 5 different simulated completed datasets, replacing each missing value with a set 
of plausible values based on the other available values for that variable. The multiply 
imputed data sets were then analyzed by using standard procedures for complete data and 
combining the results from these analyses. Missing values requiring imputation included: 
socioeconomic status (n = 300), household size (n = 77), season of pregnancy start (n = 
217), alcohol (n = 413), binge drinking (n = 1233), smoking (n = 671), and gestational age 
(n = 217).
Interactions on a multiplicative scale were tested by creating 4 groups of exposure: no 
exposure to either factor, exposure to 1 factor (or the other), and exposure to both factors. 
Only children in any of the 4 groups were included in the analysis. Those with missing data 
in either factor of a pair were not included in the analyses. The group of no exposure to 
either factor was used as a reference group in the analysis.
We also performed analyses by stratification on gestational age (preterm defined as <37 
weeks, and term defined as ≥37 weeks) and by Apgar score (<10 and 10) to test whether the 
results were independent of these as intermediate variables. Sensitivity analyses for multiple 
imputation methods were also conducted by retesting the associations using complete case 
analyses and for eliminating the possibility of recall bias by excluding mothers with 
interviews conducted postpartum. Plots of log (-log [survival rate]) against log (survival 
time) were used to check the proportionality assumption. All analysis was carried out in 
SAS version 9.2 (SAS Institute, Cary, NC).29
Results
All together, 81,066 singletons were included in the analysis. Children were followed up to a 
maximum of 11.4 years, and the mean length of follow-up time was 7.2 ± 1.5 years (mean ± 
SD), respectively. A total of 139 children were identified as having CP, of which 121 had 
sCP. The characteristics of the maternal cohort by factors associated significantly with CP or 
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sCP (vaginal infections, fever, and smoking) are presented in Table 1. Characteristics of 
mothers of the exposed and unexposed children were rather similar. Mothers who smoked 
heavily were more likely to having binged and less likely to be of higher socioeconomic 
status.
The associations between infections, fever, and smoking with CP and sCP are shown in 
Table 2. The risk of delivering an infant with CP overall or sCP specifically was not 
significantly different for women reporting any infection compared with women not 
reporting any infection. When the data were analyzed according to the type of infection, 
there was an association between vaginal infections and both overall CP and sCP risk but no 
significant associations with other infections. When vaginal infections were separated into 
untreated and treated groups, a significant association was noted for untreated vaginal 
infections and sCP.
There was no significant association of urinary tract infections with either CP or sCP. 
Maternal fever was significantly associated with having a child with CP overall but not sCP 
alone, although the association was in the same direction (Table 2). We analyzed separately 
vaginal infection and urinary tract infection for association with sCP in patients who did not 
report both infections. There were 29 women who had vaginal infections with no reported 
urinary infections and had a child with sCP (adjusted hazard ratio [aHR], 1.60, 95% 
confidence interval [CI], 1.04–2.47) and 4 women who reported urinary infections but did 
not report a vaginal infection and had a child with sCP (aHR, 0.48, 95% CI, 0.18–1.32).
We observed a significant association between heavy maternal smoking (more than 10 
cigarettes per day) during pregnancy and risk of sCP but no significant association for 
moderate smoking.
Tables 3 and 4 present interactions between significant findings in our study. The interaction 
for vaginal infections and heavy smoking was analyzed for sCP (Table 3), and the 
interaction for fever with vaginal infections was analyzed for overall CP (Table 4). There 
were no deviations from the multiplicative model for the interaction of fever with vaginal 
infection in overall CP. However, the interaction for untreated vaginal infections with heavy 
smoking showed a slight excess from the multiplicative model.
There were only 3176 preterm births in our cohort and they accounted for 32 cases of CP 
and 29 cases of sCP. In children born at term, vaginal infections and heavy smoking were 
significantly associated with the outcome sCP (aHR, 1.70; 95% CI, 1.08–2.67; and aHR, 
1.79; 95% CI, 1.02–3.15, respectively). Additionally, the association of CP with maternal 
fever was also significant in children born at term (aHR, 1.63; 95% CI, 1.09–2.44). These 3 
associations were not statistically significant in children born preterm (aHR, 1.59; 95% CI, 
0.51–4.94; aHR, 1.70; 95% CI, 0.71–4.06; aHR, 0.93; 95% CI, 0.35–2.49, respectively).
We additionally stratified by Apgar score (10 or <10) (Tables 5 and 6). For births that had a 
normal Apgar score of 10 (n=74,506, 93%), the associations of fever and heavy smoking 
with overall CP as well as the association between heavy smoking and sCP were 
significantly positive and even higher than in the total group, whereas in births with Apgar 
score less than 10 (n = 5957, 7%), the point estimates were close to 1, and associations were 
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not statistically significant. Conversely, the association of untreated vaginal infection with 
sCP was significant only in children with Apgar less than 10 with a marked increase in point 
estimate.
Sensitivity analyses comparing our study results to complete case analyses and analysis 
excluding mothers with interviews conducted postpartum are presented in Table 7.
In 619 births, mothers were interviewed after the child was delivered. After excluding these 
children from the analysis, results were similar to those in the study. Furthermore, results 
were similar when using complete case analyses in place of imputation methods.
Comment
After adjustment for available potential confounders maternal report of prenatal fever, heavy 
smoking, and vaginal infections were significantly associated with an increased risk of CP. 
All vaginal infections and fever were associated with overall CP. All vaginal infections, 
untreated vaginal infections, and heavy smoking were associated with sCP. This suggests 
that there may be differences between risk factors for spastic versus nonspastic CP. The 
association of vaginal infections and heavy smoking with sCP occurred in term birth, 
eliminating the possibility that they entirely were due to their association with preterm birth.
We additionally conducted a stratified analysis by Apgar score. The stratification by Apgar 
score showed that vaginal infection, particularly untreated vaginal infections, were strongly 
associated with sCP in children with a suboptimal Apgar score (<10) at 5 minutes after 
delivery. This indicates that fetal distress expressed as a lower Apgar score is either an 
intermediate or effect modifier in the association between vaginal infection and sCP.
Our data also showed that sCP was associated with untreated but not with treated vaginal 
infections. The cohort size was, however, too small to ascertain that successful treatment 
accounts for this finding.
In our study, questions were asked specifically about vaginal infections and urinary tract 
infections separately in a way that it is unlikely that women would confuse one with the 
other. In previous studies showing association between urogenital infections and CP, vaginal 
infections were not separated from other infections of the urogenital tract.30–33 The strength 
of our study is that we were able to address separately self-reported untreated vaginal 
infections, treated vaginal infections and urinary infections. Furthermore, all data are 
prospectively collected prior to the outcome CP.
In this study we showed fever to be associated with CP, but we did not separate fever from 
infection vs other sources of hyperthermia such as using a solarium or sauna. It is, however, 
unlikely women will classify elevated body temperature due to these exposures as fever. 
Hyperthermia during pregnancy has been associated with other neurological disorders in 
children,7,34–37 but some reports were limited to perinatal fever.7,8,34,35
Our results suggest that heavy rather than low to moderate smoking is responsible for the 
association between smoking and CP, but we do not have sufficient data to rule out an 
Streja et al. Page 6
Am J Obstet Gynecol. Author manuscript; available in PMC 2015 July 23.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
association between moderate smoking and CP. A large case-control study found an 
association between CP and smoking in pregnancy16 but did not report associations by level 
of smoking. Maternal smoking during pregnancy is associated with placental malformation 
and malfunction, 13 fetal growth restriction38 and preterm deliveries.39 Smoking effect may 
be mediated by these factors.
In the group of children that were exposed to smoking and vaginal infection, we noted a 
slight deviation from the multiplicative model, which led to a modest excess of risk of sCP 
for those exposed to both. It is conceivable that a placenta abnormality caused by heavy 
smoking is creating a hypoxic environment, 13 which exacerbates the detrimental effects of 
the presumed fetal inflammatory response induced by infection. However, this association 
demonstrated a modest excess in risk is based on small numbers. Replication in larger 
datasets is warranted.
Urinary tract infections, as defined for this analysis, were not associated with an increased 
risk of CP. We cannot, however, rule out that severe urinary tract infection requiring 
antibiotic treatments or hospitalizations are a risk factor for CP. A large recent analysis did 
not find a statistically significant association of urinary tract infections and CP.40 A case-
control study showed urinary tract infections to be associated with CP41 but was subject to 
differential recall bias because it used retrospective interviews after CP diagnosis.
A strength of our study is that our data are most likely free of differential recall bias because 
exposures were all self-reported prior to the diagnosis of CP, and sensitivity analyses 
excluding the births in which interviews were conducted after delivery further showed 
similar results. An additional strength of our study is the inclusion of cases believed by the 
patient not to require medical attention. In addition, our data are using the Danish National 
Cerebral Palsy Register, which includes only cases confirmed by expert reviews.
Limitations of our study include the fact that our data on infections were self-reported and 
limited to those addressed in the interviews and could therefore not differentiate fungal from 
bacterial vaginal infections. Also, because maternal infection reports could not be 
confirmed, nondifferential misclassification of exposure is possible and likely. The 
population studied was relatively homogeneous, and our data should be confirmed in 
populations with other ethnic groups.
We used multiple imputation methods to fill in missing values to maximize the number of 
observations used in each analysis, which may have led to some loss of precision in the 
estimates. However, sensitivity analysis using complete cases without missing data resulted 
in similar associations. Because we used only women who completed both interviews, we 
could not ascertain that the women who missed only 1 interview were missing at random.
Additionally, because point estimates were never larger than 2, even when significant and 
confidence intervals were wide, most likely due to small numbers, these associations should 
be replicated in other and larger databases to corroborate our findings. Although data were 
available for a large number of confounders in our cohort, we were able to adjust only for 
identified confounders with available data, and we cannot exclude the possibility of residual 
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confounding. Moreover, because this an observational cohort study, we cannot assume that 
associations imply causal relationships.
In summary, our study adds support to the fact that maternal vaginal infection, maternal 
fever, and maternal smoking, during early and mid pregnancy, are associated with increased 
risks of CP and/or sCP in the child. Whether this is related to the infection itself or changes 
in the immune system in not known.42
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